Literature DB >> 3804208

Selective hepatobiliary transport defect for organic anions and neutral steroids in mutant rats with hereditary-conjugated hyperbilirubinemia.

P L Jansen, G M Groothuis, W H Peters, D F Meijer.   

Abstract

Mutant rats (TM rats) with abnormal hepatic excretory function were used to study biliary transport of dibromosulfophthalein, ouabain, tributylmethyl ammonium, cholate and taurocholate. In whole animals, dibromosulfophthalein and ouabain clearance is reduced to 7 and 37% of normal, respectively, due to severely impaired excretion from liver to bile. Initial uptake rates of these agents are relatively little affected. In the isolated perfused liver preparation, dibromosulfophthalein is retained within liver and perfusion medium, and the 60-min recovery on bile is reduced to 1.5 vs 75% in normal controls. Biliary excretion of cholate, taurocholate and the quaternary ammonium cation, [14C]tributylmethyl ammonium, is not impaired. These results provide evidence for a selective defect of organic anion and neutral steroid transport in TM rats and confirm that multiple pathways exist for the hepatobiliary excretion of organic anions, neutral steroids, bile acids and cations. Bile flow in whole animals and in the isolated perfused liver is reduced to 50 and 30% of normal, respectively. This suggests that a normal function of the excretory systems for organic anions and neutral steroids is important for the maintenance of normal bile flow.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3804208     DOI: 10.1002/hep.1840070116

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  14 in total

Review 1.  Interplay of drug metabolizing enzymes with cellular transporters.

Authors:  Michaela Böhmdorfer; Alexandra Maier-Salamon; Juliane Riha; Stefan Brenner; Martina Höferl; Walter Jäger
Journal:  Wien Med Wochenschr       Date:  2014-09-10

2.  Dexamethasone- and osmolarity-dependent expression of the multidrug-resistance protein 2 in cultured rat hepatocytes.

Authors:  R Kubitz; U Warskulat; M Schmitt; D Häussinger
Journal:  Biochem J       Date:  1999-06-15       Impact factor: 3.857

3.  New hepatocellular diffusion model for analysis of hepatobiliary transport processes of drugs.

Authors:  H Yasui; K Yamaoka; T Nakagawa
Journal:  J Pharmacokinet Biopharm       Date:  1995-04

4.  Electron-microscopic demonstration of multidrug resistance protein 2 (Mrp2) retrieval from the canalicular membrane in response to hyperosmolarity and lipopolysaccharide.

Authors:  F Dombrowski; R Kubitz; A Chittattu; M Wettstein; N Saha; D Häussinger
Journal:  Biochem J       Date:  2000-05-15       Impact factor: 3.857

5.  Hepatic, intestinal and renal transport of 1-naphthol-beta-D-glucuronide in mutant rats with hereditary-conjugated hyperbilirubinemia.

Authors:  M H de Vries; F A Redegeld; A S Koster; J Noordhoek; J G de Haan; R P Oude Elferink; P L Jansen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-11       Impact factor: 3.000

6.  Inhibition of glutathione-conjugate secretion from isolated hepatocytes by dipolar bile acids and other organic anions.

Authors:  R P Oude Elferink; R Ottenhoff; A Radominska; A F Hofmann; F Kuipers; P L Jansen
Journal:  Biochem J       Date:  1991-02-15       Impact factor: 3.857

7.  Hepatocanalicular organic-anion transport is regulated by protein kinase C.

Authors:  H Roelofsen; R Ottenhoff; R P Oude Elferink; P L Jansen
Journal:  Biochem J       Date:  1991-09-15       Impact factor: 3.857

8.  Relationship between biliary excretion of bilirubin and glutathione disulfide.

Authors:  Y Kuronuma; H Yoshida; M Iijima; T Harada
Journal:  Gastroenterol Jpn       Date:  1993-04

9.  Defective ATP-dependent bile canalicular transport of organic anions in mutant (TR-) rats with conjugated hyperbilirubinemia.

Authors:  T Kitamura; P Jansen; C Hardenbrook; Y Kamimoto; Z Gatmaitan; I M Arias
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

10.  Hepatobiliary transport of glutathione and glutathione conjugate in rats with hereditary hyperbilirubinemia.

Authors:  R P Elferink; R Ottenhoff; W Liefting; J de Haan; P L Jansen
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.